These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8529997)

  • 1. Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.
    Akita H; Chiba H; Tsuji M; Hui SP; Takahashi Y; Matsuno K; Kobayashi K
    Hum Genet; 1995 Nov; 96(5):521-6. PubMed ID: 8529997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of a polymorphism (G-->A transition) in the -75 position of the apolipoprotein A-I gene promoter on serum high density lipoprotein-cholesterol levels in Japanese hyperlipidemic subjects.
    Tashiro J; Morisaki N; Kobayashi J; Bujo H; Kanzaki T; Murano S; Saito Y
    J Atheroscler Thromb; 2001; 8(3):95-100. PubMed ID: 11866037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.
    Inazu A; Jiang XC; Haraki T; Yagi K; Kamon N; Koizumi J; Mabuchi H; Takeda R; Takata K; Moriyama Y
    J Clin Invest; 1994 Nov; 94(5):1872-82. PubMed ID: 7962532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women.
    Motohashi Y; Maruyama T; Murata M; Nakano S; Maruyama C; Kyotani S; Tsushima M; Saruta T
    Nutr Metab Cardiovasc Dis; 2004 Feb; 14(1):6-14. PubMed ID: 15053158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
    Inazu A; Koizumi J; Haraki T; Yagi K; Wakasugi T; Takegoshi T; Mabuchi H; Takeda R
    Hum Genet; 1993 Mar; 91(1):13-6. PubMed ID: 8454281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia.
    Mitchell RJ; Earl L; Williams J; Bisucci T; Gasiamis H
    Hum Biol; 1994 Feb; 66(1):13-25. PubMed ID: 7908890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation.
    Dachet C; Poirier O; Cambien F; Chapman J; Rouis M
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):507-15. PubMed ID: 10669650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
    J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
    Hannuksela ML; Liinamaa MJ; Kesäniemi YA; Savolainen MJ
    Atherosclerosis; 1994 Sep; 110(1):35-44. PubMed ID: 7857368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
    Inazu A; Nishimura Y; Terada Y; Mabuchi H
    J Hum Genet; 2001; 46(4):172-7. PubMed ID: 11322655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.